BIASCO, ELISA Statistiche
BIASCO, ELISA
DIP. DI RICERCA TRASLAZIONALE E DELLE NUOVE TECNOLOGIE IN MEDICINA E CHIRURGIA - disattivato (attivo dal 19/09/2012 al 31/12/2019)
Bevacizumab and Paclitaxel in Advanced, Hormone Receptor-Positive Breast Cancer: Multifactor Dimensionality Reduction Methodology to Identify Best Overall Survival
2026-01-01 Coltelli, Luigi; Orlandi, Paola; Finale, Chiara; Musettini, Gianna; Masini, Luna Chiara; Scalese, Marco; Soria, Giulia; Sartori, Elena; Nodari, Ylenia; Arrighi, Giada; Bandini, Arianna; Banchi, Marta; Tacchi, Costanza; Tang, Donghao; Salvadori, Barbara; Tanganelli, Lucia; Giovannelli, Simona; Pistelli, Mirco; Cupini, Samanta; Lucchesi, Maurizio; Cosimi, Alessandro; Lorenzini, Giulia; Biasco, Elisa; Caparello, Chiara; Acconci, Giulia; Fontana, Eloise; Bona, Eleonora; Farnesi, Azzurra; Pellino, Antonio; Marini, Andrea; De Maio, Ermelinda; Stasi, Irene; Barbara, Cecilia; Sammarco, Enrico; Rosada, Javier; Allegrini, Giacomo; Bocci, Guido
Pharmacogenetics of androgen signaling in prostate cancer: focus on castration resistance and predictive biomarkers of response to treatment
2018-01-01 Del Re, Marzia; Crucitta, Stefania; Restante, Giuliana; Rofi, Eleonora; Arrigoni, Elena; Biasco, Elisa; Sbrana, Andrea; Coppi, Erika; Galli, Luca; Bracarda, Sergio; Santini, Daniele; Danesi, Romano
Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680â7
2018-01-01 Del Re, Marzia; Biasco, Elisa; Crucitta, Stefania; Derosa, Lisa; Rofi, Eleonora; Orlandini, Cinzia; Miccoli, Mario; Galli, Luca; Falcone, Alfredo; Jenster, Guido W.; van Schaik, Ron H.; Danesi, Romano
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients
2017-01-01 DEL RE, Marzia; Biasco, Elisa; Crucitta, Stefania; Derosa, Lisa; Rofi, Eleonora; Orlandini, Cinzia; Miccoli, Mario; Galli, Luca; Falcone, Alfredo; Jenster, Guido W.; van Schaik, Ron H.; Danesi, Romano
Impact of a supportive care service for cancer outpatients: management and reduction of hospitalizations. Preliminary results of an integrated model of care
2016-01-01 Antonuzzo, Andrea; Vasile, Enrico; Sbrana, A.; Lucchesi, Maurizio; Galli, L.; Brunetti, I. M.; Musettini, Gianna; Farnesi, Azzurra; Biasco, Elisa; Virgili, N.; Falcone, Alfredo; Ricci, S.
Feasibility and efficacy of 223Ra-dichloride (223Ra) to treat bone metastases in patients (pts) with castration resistant prostate cancer (mCRPC)
2015-01-01 Farnesi, A.; Mazzarri, S.; Boni, G.; Galli, L.; Cianci, C.; Borso', Elisa; Marconcini, R.; Biasco, Elisa; Derosa, Lisa; Sbrana, A.; Antonuzzo, A.; Ricci, S.; Volterrai, D.; Falcone, Alfredo
metastatic well or moderately differentiated Neuroendocrine tumors (WDNET) treated with sequence of different Somatostatin Analogs (SSA) - Lanreotide LAR (La), Octreotide LAR (Oc): a single center experience
2015-01-01 Marconcini, R.; Ricci, S.; Galli, L.; Antonuzzo, A.; Farnesi, A.; Derosa, Lisa; Biasco, Elisa; Falcone, Alfredo
New Prognostic factors for second-line targeted therapy (TT) in metastatic renal cell carcinoma (mRCC).
2015-01-01 Derosa, Lisa; Guida, A.; Albiges, L.; Massard, C.; Loriot, Y.; Biasco, Elisa; Farnesi, A.; Marconcini, R.; Galli, L.; Falcone, Alfredo; Fizazi, K.; Escudier, B.
predictive factors of efficacy of somatostatine analogs (SSA) in gastroenteropancreatic neuroendocrine tumors (GEP-NET)
2015-01-01 Ricci, S.; Marconcini, R.; Galli, L.; Antonuzzo, A.; Farnesi, A.; Derosa, Lisa; Biasco, Elisa; Falcone, Alfredo
Small-bowel neuroendocrine tumor and retroperitoneal fibrosis: Efficacy of octreotide and tamoxifen
2015-01-01 Biasco, Elisa; Antonuzzo, Andrea; Galli, Luca; Baldi, Giacomo Giulio; Derosa, Lisa; Marconcini, Riccardo; Farnesi, Azzurra; Ricci, Sergio; Falcone, Alfredo
EARLY AND COMPLETE CLINICAL RESPONSE TO SUNITINIB IN A PATIENT WITH METASTATIC RENAL CANCER
2014-01-01 Biasco, E; Farnesi, A; Aringhieri, G; Derosa, L; Marconcini, R; Galli, L; Antonuzzo, A; Cianci, C; Ricci, S; Caramella, D; Falcone, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Bevacizumab and Paclitaxel in Advanced, Hormone Receptor-Positive Breast Cancer: Multifactor Dimensionality Reduction Methodology to Identify Best Overall Survival | 1-gen-2026 | Coltelli, Luigi; Orlandi, Paola; Finale, Chiara; Musettini, Gianna; Masini, Luna Chiara; Scalese, Marco; Soria, Giulia; Sartori, Elena; Nodari, Ylenia; Arrighi, Giada; Bandini, Arianna; Banchi, Marta; Tacchi, Costanza; Tang, Donghao; Salvadori, Barbara; Tanganelli, Lucia; Giovannelli, Simona; Pistelli, Mirco; Cupini, Samanta; Lucchesi, Maurizio; Cosimi, Alessandro; Lorenzini, Giulia; Biasco, Elisa; Caparello, Chiara; Acconci, Giulia; Fontana, Eloise; Bona, Eleonora; Farnesi, Azzurra; Pellino, Antonio; Marini, Andrea; De Maio, Ermelinda; Stasi, Irene; Barbara, Cecilia; Sammarco, Enrico; Rosada, Javier; Allegrini, Giacomo; Bocci, Guido | |
| Pharmacogenetics of androgen signaling in prostate cancer: focus on castration resistance and predictive biomarkers of response to treatment | 1-gen-2018 | Del Re, Marzia; Crucitta, Stefania; Restante, Giuliana; Rofi, Eleonora; Arrigoni, Elena; Biasco, Elisa; Sbrana, Andrea; Coppi, Erika; Galli, Luca; Bracarda, Sergio; Santini, Daniele; Danesi, Romano | |
| Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680â7 | 1-gen-2018 | Del Re, Marzia; Biasco, Elisa; Crucitta, Stefania; Derosa, Lisa; Rofi, Eleonora; Orlandini, Cinzia; Miccoli, Mario; Galli, Luca; Falcone, Alfredo; Jenster, Guido W.; van Schaik, Ron H.; Danesi, Romano | |
| The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients | 1-gen-2017 | DEL RE, Marzia; Biasco, Elisa; Crucitta, Stefania; Derosa, Lisa; Rofi, Eleonora; Orlandini, Cinzia; Miccoli, Mario; Galli, Luca; Falcone, Alfredo; Jenster, Guido W.; van Schaik, Ron H.; Danesi, Romano | |
| Impact of a supportive care service for cancer outpatients: management and reduction of hospitalizations. Preliminary results of an integrated model of care | 1-gen-2016 | Antonuzzo, Andrea; Vasile, Enrico; Sbrana, A.; Lucchesi, Maurizio; Galli, L.; Brunetti, I. M.; Musettini, Gianna; Farnesi, Azzurra; Biasco, Elisa; Virgili, N.; Falcone, Alfredo; Ricci, S. | |
| Feasibility and efficacy of 223Ra-dichloride (223Ra) to treat bone metastases in patients (pts) with castration resistant prostate cancer (mCRPC) | 1-gen-2015 | Farnesi, A.; Mazzarri, S.; Boni, G.; Galli, L.; Cianci, C.; Borso', Elisa; Marconcini, R.; Biasco, Elisa; Derosa, Lisa; Sbrana, A.; Antonuzzo, A.; Ricci, S.; Volterrai, D.; Falcone, Alfredo | |
| metastatic well or moderately differentiated Neuroendocrine tumors (WDNET) treated with sequence of different Somatostatin Analogs (SSA) - Lanreotide LAR (La), Octreotide LAR (Oc): a single center experience | 1-gen-2015 | Marconcini, R.; Ricci, S.; Galli, L.; Antonuzzo, A.; Farnesi, A.; Derosa, Lisa; Biasco, Elisa; Falcone, Alfredo | |
| New Prognostic factors for second-line targeted therapy (TT) in metastatic renal cell carcinoma (mRCC). | 1-gen-2015 | Derosa, Lisa; Guida, A.; Albiges, L.; Massard, C.; Loriot, Y.; Biasco, Elisa; Farnesi, A.; Marconcini, R.; Galli, L.; Falcone, Alfredo; Fizazi, K.; Escudier, B. | |
| predictive factors of efficacy of somatostatine analogs (SSA) in gastroenteropancreatic neuroendocrine tumors (GEP-NET) | 1-gen-2015 | Ricci, S.; Marconcini, R.; Galli, L.; Antonuzzo, A.; Farnesi, A.; Derosa, Lisa; Biasco, Elisa; Falcone, Alfredo | |
| Small-bowel neuroendocrine tumor and retroperitoneal fibrosis: Efficacy of octreotide and tamoxifen | 1-gen-2015 | Biasco, Elisa; Antonuzzo, Andrea; Galli, Luca; Baldi, Giacomo Giulio; Derosa, Lisa; Marconcini, Riccardo; Farnesi, Azzurra; Ricci, Sergio; Falcone, Alfredo | |
| EARLY AND COMPLETE CLINICAL RESPONSE TO SUNITINIB IN A PATIENT WITH METASTATIC RENAL CANCER | 1-gen-2014 | Biasco, E; Farnesi, A; Aringhieri, G; Derosa, L; Marconcini, R; Galli, L; Antonuzzo, A; Cianci, C; Ricci, S; Caramella, D; Falcone, A |